Comparative analysis of the effectiveness of abiraterone before and after docetaxel in patients with metastatic castration-resistant prostate cancer

Baishideng Publishing Group, World Journal of Clinical Oncology, 4(6), p. 64

Journal article published in 2015 by Raji Shameem, Muhammad Saad Hamid

, Kevin Y. Xu, Shenhong Wu

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving allowed

Upload

Policy details

Data provided by

AIM: To study the efficacy and safety of abiraterone in patients with and without prior chemotherapy.